| 2022-10-03 | Sale | Verve Therapeutics, Inc. VERV | Chief Executive Officer | 50,000 0.2839% | $33.65 | $1.68M | ||
| 2022-08-10 | Sale | Verve Therapeutics, Inc. VERV | Chief Executive Officer | 50,000 0.0818% | $29.90 | $1.5M | -36.67% | |
| 2022-07-19 | Sale | Verve Therapeutics, Inc. VERV | Chief Executive Officer | 100,000 0.1619% | $29.90 | $2.99M | -34.75% | |
| 2022-01-04 | Sale | Verve Therapeutics, Inc. VERV | Chief Executive Officer | 3,740 0.0085% | $39.90 | $149,226 | -29.9% | |
| 2021-12-28 | Sale | Verve Therapeutics, Inc. VERV | Chief Executive Officer | 13,386 0.0553% | $39.90 | $534,101 | -26.91% | |
| 2021-12-27 | Sale | Verve Therapeutics, Inc. VERV | Chief Executive Officer | 84,000 0.3141% | $40.20 | $3.38M | -34.19% | |
| 2021-12-23 | Sale | Verve Therapeutics, Inc. VERV | Chief Executive Officer | 114,000 0.4097% | $39.90 | $4.55M | -36.08% | |
| 2021-12-22 | Sale | Verve Therapeutics, Inc. VERV | Chief Executive Officer | 114,000 0.42% | $38.71 | $4.41M | -32.17% | |
| 2021-06-21 | Verve Therapeutics, Inc. VERV | Chief Executive Officer | 5,000 0.0323% | $19.00 | $95,000 | -7.41% |